The 20 Best Acute Monoblastic Leukemia (AmoL) Doctors Near Me

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Daniel Pollyea is a Hematologist in Aurora, Colorado. Dr. Pollyea is rated as an Elite provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Monoblastic Leukemia (AmoL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Wanggang Zhang practices in Xi'an, China. Zhang is rated as an Elite expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Their top areas of expertise are Acute Monoblastic Leukemia (AmoL), Acute Myeloid Leukemia (AML), Leukemia, and Multiple Myeloma.

Bo Lei practices in Xi'an, China. Mr. Lei is rated as an Elite expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Monoblastic Leukemia (AmoL), Methicillin-Resistant Staphylococcus Aureus (MRSA), Acute Myeloid Leukemia (AML), and Leukemia.

Courtney Dinardo is a Hematologist in Houston, Texas. Dr. Dinardo is rated as an Elite provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Shams Bufalino is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Bufalino is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration.

Pinal Chokshi is a Hematologist and an Oncologist in Crystal Lake, Illinois. Dr. Chokshi is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

. Dr. Jaishankar is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Hien Liu is an Internal Medicine provider in Tampa, Florida. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Multiple Myeloma, Peripheral T-Cell Lymphoma, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Liu is currently accepting new patients.

Adam Bagg is a Hematologist in Philadelphia, Pennsylvania. Dr. Bagg is rated as a Distinguished provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Castleman Disease, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multicentric Castleman Disease (MCD), and Bone Marrow Aspiration.

Dr. Stellman grew up in Texas, Oklahoma and Georgia. He earned a bachelor’s in biological sciences from Oklahoma State University in Stillwater, Oklahoma and graduated with his doctor of medicine from the University of Oklahoma College of Medicine in Oklahoma City. Dr. Stellman completed a family medicine residency at Saint Joseph Hospital in Denver, Colorado. He is board certified in family medicine. As a family medicine physician, Dr. Stellman’s clinical interests include providing care for patients of all ages and stages of life. His practice covers preventive care, mental health, sports medicine, diabetes, hypertension, minor procedures and everything in between. He is especially passionate about preventive care, overall health and well-being.“I will always encourage you to live your best life with healthy eating, regular exercise, stress management and good sleep. If there's a problem we can address with healthy lifestyle changes, I prefer to take that approach first.”When not seeing patients, Dr. Stellman enjoys music (live music and collecting records), hiking, camping, traveling, carpentry and most importantly, spending his time with his three children and golden retriever. Dr. Stellman is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Juvenile Myoclonic Epilepsy, Type 2 Diabetes (T2D), Hypertension, and Familial Hypertension.

Jie Liu practices in Beijing, China. Mr. Liu is rated as a Distinguished expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Cerebral Hypoxia, Diarrhea, Lung Cancer, Endoscopy, and Thyroidectomy.

Malgorzata Mcmasters is an Internal Medicine provider in Boston, Massachusetts. Dr. Mcmasters is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myelomonocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

Ravi Krishnadasan is an Oncologist in Tucson, Arizona. Dr. Krishnadasan is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Krishnadasan is currently accepting new patients.

Mark J. Levis, M.D., Ph.D., professor of oncology, medicine and pharmacology in the Division of Hematologic Malignancies at the Johns Hopkins University School of Medicine, co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs the Adult Leukemia Service at the Johns Hopkins Sidney Kimmel Cancer Center. In addition to his role within the Kimmel Cancer Center, he serves on the faculty for the Johns Hopkins Graduate Training Program in Cellular and Molecular Medicine, a Ph.D. program that prepares scientists to conduct laboratory research at the cellular and molecular level that is designed to have a direct impact on the understanding of human diseases. Dr. Levis has expertise in acute and chronic myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes. Dr. Levis received his medical degree at the University of California, San Francisco School of Medicine, where he also earned his Ph.D. in Biochemistry. He completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology. Dr. Levis is a member of the American Society of Hematology, the American Society of Clinical Oncology and the European Hematology Association. He is an ad hoc member of the Oncology Drug Advisory Committee, as well as an ad hoc manuscript referee for peer-reviewed journals such as New England Journal of Medicine; Leukemia; Clinical Cancer Research; and The American Journal of Hematology. Dr. Levis has earned numerous awards, such as the Daniel Nathans Research Award from Johns Hopkins University, the Osler Housestaff Teaching Award, the Director's Teaching Award in Clinical Science, and the Advanced Clinical Research Award from the American Society of Clinical Oncology. Dr. Levis’ laboratory research focuses on the development of molecularly-targeted therapies for leukemia. He is actively involved in the pre-clinical and clinical development of small molecule inhibitors of protein kinases, including FLT3. The research involves studying the biochemical effects of these inhibitors on samples taken from leukemia patients, with the broad goal of identifying and validating novel molecular therapeutic targets in these hematopoietic malignancies. While Dr. Levis plays a key role in the pre-clinical development of these therapies, he is particularly interested in translating this research to the bedside of his patients by using correlative studies to incorporate these novel therapies into existing treatments. In addition to his work in both the clinic and the laboratory, Dr. Levis has also conducted talks, mentorship and teaching lectures, and published extensively in the top journals in his field, including Leukemia; Blood; and the New England Journal of Medicine. Dr. Levis is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

David Grinblatt, MD, a hematologist at Endeavor Health Cancer Institute, specializes in diagnosing and treating blood disorders using the most advanced and effective therapies available. He is actively involved in bringing CAR-T cell therapy to patients, reflecting his commitment to innovation and personalized care. Dr. Grinblatt values optimism and clear communication and works closely with patients to develop treatment plans that align with their unique situation and diagnosis. Dr. Grinblatt is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

As a medical oncologist, I care for patients throughout their cancer journey, offering a combination of compassionate care and cutting-edge expertise. My areas of expertise include CART, allogeneic and autologous stem cell transplants and hematologic malignancies, with focus on lymphomas. I am committed to providing compassionate and innovative care to my patients. Throughout my career, I have held several academic positions, including Clinical Assistant Professor at the University of Pittsburgh Medical Center and acting Clinical Instructor at the University of Washington Medical Center. My dedication to medical research and education is evident in my publications in medical journals, covering topics such as hematopoietic cell transplantation and innovative treatment protocols for hematologic cancers. I am board-certified in medical oncology. I received my medical degree from Saint Joseph University Medical School in Beirut. I completed my residency in internal medicine at Staten Island University Hospital in New York and my fellowship in medical oncology at the University of Washington School of Medicine and Fred Hutchinson Cancer Center in Seattle. For those seeking an oncologist who combines expertise with a compassionate approach, I am dedicated to ensuring the highest quality care and supporting my patients through every step of their cancer journey. Dr. Farah is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Lynch is a board-eligible and fellowship-trained cancer physician specializing in medical oncology. He attended Georgetown University School of Medicine, where he earned his medical degree. He completed his residency at Cleveland Clinic Foundation, and his fellowship in medical oncology at Allegheny General Hospital. Dr. Lynch is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Matt Kalaycio is a Hematologist in Cleveland, Ohio. Dr. Kalaycio is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Kamble is Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble's clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease. Dr. Kamble is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Multiple Myeloma, Graft Versus Host Disease (GvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.